A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation

PHASE3CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

November 21, 2024

Study Completion Date

December 21, 2024

Conditions
Agitation in Patients with Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Interventions
DRUG

AXS-05

AXS-05 tablets, taken twice daily

DRUG

Placebo

Placebo tablets, taken twice daily

Trial Locations (55)

10312

Clinical Research Site, Staten Island

11229

Clinical Research Site, Brooklyn

11598

Clinical Research Site, Woodmere

12553

Clinical Research Site, New Windsor

22205

Clinical Research Site, Arlington

28211

Clinical Research Site, Charlotte

28601

Clinical Research Site, Hickory

30349

Clinical Research Site, College Park

30912

Clinical Research Site, Augusta

31909

Clinical Research Site, Columbus

32807

Clinical Research Site, Orlando

33012

Clinical Research Site, Hialeah

33014

Clinical Research Site, Miami Gardens

Clinical Research Site, Miami Lakes

33024

Clinical Research Site, Hollywood

33025

Clinical Research Site, Pembroke Pines

33126

Clinical Research Site, Miami

33135

Clinical Research Site, Miami

33145

Clinical Research Site, Miami

33155

Clinical Research Site, Miami

33165

Clinical Research Site, Miami

33173

Clinical Research Site, Miami

33175

Clinical Research Site, Miami

33467

Clinical Research Site, Green Acres

33511

Clinical Research Site, Brandon

33614

Clinical Research Site, Tampa

33634

Clinical Research Site, Tampa

34134

Clinical Research Site, Bonita Springs

34741

Clinical Research Site, Kissimmee

44130

Clinical Research Site, Middleburg Heights

48085

Clinical Research Site, Troy

48307

Clinical Research Site, Rochester Hills

48532

Clinical Research Site, Flint

63005

Clinical Research Site, Chesterfield

67214

Clinical Research Site, Wichita

70072

Clinical Research Site, Marrero

75149

Clinical Research Site, Mesquite

77429

Clinical Research Site, Cypress

77478

Clinical Research Site, Sugarland

78229

Clinical Research Site, San Antonio

78737

Clinical Research Site, Austin

85282

Clinical Research Site, Tempe

85381

Clinical Research Site, Peoria

85710

Clinical Research Site, Tucson

90720

Clinical Research Site, Los Alamitos

90807

Clinical Research Site, Long Beach

91303

Clinical Research Site, Canoga Park

91790

Clinical Research Site, West Covina

94596

Clinical Research Site, Walnut Creek

02184

Clinical Research Site, Braintree

08009

Clinical Research Site, Berlin

08755

Clinical Research Site, Toms River

05701

Clinical Research Site, Rutland

00961

Clinical Research Site, Bayamón

00918

Clinical Research Site, San Juan

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY

NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation | Biotech Hunter | Biotech Hunter